Cathie Wood's ARK ETF focuses on Brera Holdings and offloads Roku stock

Cathie Wood's ARK ETFs made notable portfolio adjustments on September 18, 2025, with a significant purchase of 6.5 million shares of Brera Holdings PLC (BREA) totaling $49.7 million, indicating a strong bullish stance. Concurrently, ARK divested 47,474 shares of Roku Inc (ROKU) for $4.6 million and 43,157 shares of Tempus AI Inc (TEM), suggesting a strategic rebalancing or profit-taking. The firm also continued to build positions in biotechnology companies like Arcturus Therapeutics and ATAI Life Sciences, as well as autonomous technology firms including AeroVironment, Baidu, and Pony AI, reinforcing its focus on disruptive innovation sectors.

Analysis

On September 18, 2025, ARK Investment Management executed a significant portfolio reallocation, making a substantial new investment in Brera Holdings PLC (BREA) with the purchase of 6,500,001 shares for approximately $49.7 million. This sizable acquisition, spread across the ARKK, ARKW, and ARKF ETFs, signals a strong new bullish conviction. In parallel, ARK divested from key holdings, selling 47,474 shares of Roku Inc (ROKU) for $4.7 million and 43,157 shares of Tempus AI Inc (TEM) for $3.7 million, suggesting a strategic rebalancing or a revised outlook on these specific names. The firm continued its thematic accumulation in other areas, adding to positions in biotechnology through Arcturus Therapeutics (ARCT) and ATAI Life Sciences (ATAI), and reinforcing its exposure to autonomous technology and AI by acquiring shares in AeroVironment (AVAV), Baidu (BIDU), and Pony AI (PONY). These daily trades demonstrate a clear strategy of concentrating capital into a new high-conviction idea while trimming other positions and continuing methodical investments in its core innovation themes.

Key Decisions for Investors

• Given the magnitude of ARK's nearly $50 million investment, investors should conduct immediate due diligence on Brera Holdings PLC (BREA) to understand the fundamental thesis driving this new, high-conviction position.
• The significant sales of Roku (ROKU) and Tempus AI (TEM) warrant a review of these holdings, as divestment by a key innovation-focused manager could signal a change in the growth narrative or simply represent profit-taking.
• Note the continued capital allocation to the biotechnology (ARCT, ATAI) and autonomous technology (AVAV, BIDU, PONY) sectors, which confirms these remain core themes for ARK and may present opportunities for investors aligned with this long-term vision.
• Traders and investors tracking fund flows should interpret this activity as a significant portfolio rotation within ARK's ETFs, rather than a broad market sentiment shift.